Figure 3.

Comparison of ITGA7 expression between CR patients and non‐CR patients. A, The percentage of patients achieved CR and patients who did not achieve CR; B, comparison of ITGA7 mRNA expression between CR patients and non‐CR patients; C, comparison of ITGA7 protein expression between CR patients and non‐CR patients. Comparisons between groups were determined by Wilcoxon rank‐sum test. P value <.05 was considered as significant. CR, complete remission; ITGA7, integrin α7; AML, acute myeloid leukemia